Cleared Special

K003261 - CREATININE PLUS

K003261 is an FDA 510(k) clearance for CREATININE PLUS, manufactured by Roche Diagnostics Corp.. The device is a Class 2 Chemistry device with product code JFY cleared through the Special 510(k) pathway after a 29-day FDA review.

K003261 · Roche Diagnostics Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2000
Decision
29d
Days
Class 2
Risk

K003261 is an FDA 510(k) clearance for the CREATININE PLUS. Classified as Enzymatic Method, Creatinine (product code JFY), Class II - Special Controls.

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on November 16, 2000 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1225 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Roche Diagnostics Corp. devices

FDA 510(k) Submission Details - K003261

510(k) Number K003261 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 18, 2000
Decision Date November 16, 2000
Days to Decision 29 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 88d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

JFY Device Classification - Class 2, Special Controls

Product Code JFY Enzymatic Method, Creatinine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JFY Enzymatic Method, Creatinine

All 36
Devices cleared under the same product code (JFY) and FDA review panel - the closest regulatory comparables to K003261.
CLINITEK ATLAS PRO 12 REAGENT PAK SYSTEM
K021428 · Bayer Corp. · Jul 2002
WIENER LAB. CREATININA CINETICA AA
K012065 · Wiener Laboratories Saic · Oct 2001
BIOSCANNER CREATININE TEST STRIPS
K010456 · Polymer Technology Systems, Inc. · Jun 2001
VITROS CHEMISTRY PRODUCTS CREA SLIDE, VIRTROS CHEMISTRY PRODUCTS CALIBRATOR KIT 1
K001310 · Ortho-Clinical Diagnostics, Inc. · May 2000
ABBOTT QUICK START CREATINE KINASE(CK) ITEM #5A17
K912807 · Em Diagnostic Systems, Inc. · Oct 1991
REFLOTRON CREATININE TEST TABS
K913105 · Boehringer Mannheim Corp. · Aug 1991